CHROMACON LAUNCHES THE CONTICHROM DISCOVERY
Zurich.
ChromaCon launches the Contichrom Discovery, a highly automated multi-step batch FPLC system for tagged proteins and antibodies. The system is marketed through ChromaCon and its worldwide distributor channels. An overview over ChromaCon’s international partner network is available online.
The Contichrom Discovery combines two functional features in a unique piece of equipment: full single column batch functionality and automated multi-step batch purification. The system is useful for both process development specialists and for non-experts in protein purification relying on getting highly pure proteins in an easy and automated way. With an additional hard- and software upgrade, the system can be converted into a high-throughput model with the capability to purify up to 18 consecutive samples per sequence in an unattended way.
The Contichrom Discovery is a unique system aiming to facilitate and accelerate the purification of proteins for a wide customer basis in Research and Development.
More information on the Contichrom Discovery is available online and as a downloadable product brochure.
About ChromaCon
ChromaCon AG is a private Life Science Tool company located in Zürich, Switzerland, providing best-in-class process solutions to the biopharmaceutical industry. ChromaCon has developed and patented novel process principles, process control, equipment designs and operating software for batch, cyclic and continuous chromatography, providing significant CAPEX and OPEX cost savings and enabling scalable chromatographic solutions for large scale purification applications. The Contichrom® CUBE laboratory-scale equipment is co-marketed worldwide by ChromaCon and its partners. ChromaCon has provided global licenses for its process technologies to LEWA Process Technologies (Devens, MA, USA) for implementation into scale-up systems. ChromaCon also develops and markets affinity purification solutions for column and membrane chromatography applications and tools for site-specific protein conjugation.

